Richman Chemical’s CCO, Chrisopher Kulp, recently sat down with Chemistry Today and participated in a Panel Discussion on custom synthesis and contract manufacturing. Read what Chris had to say regarding process optimization and scale-up considerations in CROs by clicking the link below.
ROUTE SCOUTING, PROCESS OPTIMIZATION, AND SCALE-UP CONSIDERATIONS: DRUG DEVELOPMENT FIRMS AND CROs